A Win For Eterna Therapeutics Inc Com (New)

Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ) rocketted at $0.46, representing a gain of 48.2%. On Tue, Jan 14, 2025, ERNA:NASDAQ touched a New 2-Week High of $0.46. The stock got featured on our News Catalysts scanner on Tue, Jan 14, 2025 at 09:32 AM in the 'BIOTECH' category. From Thu, Jan 02, 2025, the stock recorded 14.29% Up Days and 50.00% Green Days
The stock spiked on Tue, Jan 14, 2025 at $0.96 with a volume of 568M+.
About Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ)
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
Top 10 Gainers:
- Smart for Life Inc. (SMFL:NASDAQ), 260%
- H&E Equipment Services, Inc. (HEES:NASDAQ), 105.48%
- Firefly Neuroscience Inc Com (AIFF:NASDAQ), 65.79%
- Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ), 48.22%
- Rigetti Computing Inc. (RGTI:NASDAQ), 47.93%
- ThredUp Inc. (TDUP:NASDAQ), 45.38%
- Cyngn Inc. (CYN:NASDAQ), 36.1%
- Nature's Miracle Holding Inc. (NMHI:NASDAQ), 35.4%
- Star Fashion Culture Holdings Limited (STFS:NASDAQ), 31.7%
- S&W Seed Company (SANW:NASDAQ), 29.66%